Nanobiotix S.A.
NBTX
$28.23
-$2.08-6.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 7.85% | 238.47% | |||
| Total Other Revenue | 7.85% | 30.58% | |||
| Total Revenue | 7.85% | 259.58% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 7.85% | 259.58% | |||
| SG&A Expenses | 7.85% | 15.02% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.85% | -9.75% | |||
| Operating Income | 7.86% | 101.80% | |||
| Income Before Tax | -7.85% | 88.54% | |||
| Income Tax Expenses | 6.25% | 113.97% | |||
| Earnings from Continuing Operations | -7.85% | 88.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.85% | 88.51% | |||
| EBIT | 7.86% | 101.80% | |||
| EBITDA | 7.84% | 102.42% | |||
| EPS Basic | -7.87% | 88.52% | |||
| Normalized Basic EPS | -7.88% | 87.14% | |||
| EPS Diluted | -7.87% | 88.55% | |||
| Normalized Diluted EPS | -7.88% | 87.14% | |||
| Average Basic Shares Outstanding | 0.00% | 0.03% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||